Vaccine advisers to the US Centers for Disease Control and Prevention are scheduled to meet Friday to discuss how to move forward with Johnson & Johnson’s Janssen coronavirus vaccine.
Vaccine advisers to the US Centers for Disease Control and Prevention are scheduled to meet Friday to discuss how to move forward with Johnson & Johnson’s Janssen coronavirus vaccine.
